RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Nanjing Vazyme Biotech Co Stocks 2024

Nanjing Vazyme Biotech Co Stocks

394.2 M

Nanjing Vazyme Biotech Co Dividend yield

5.32 %

Ticker

688105.SS

ISIN

CNE100004ZK3

In 2024, Nanjing Vazyme Biotech Co had 394.2 M outstanding stocks, a 0% change from the 394.2 M stocks in the previous year.

The Nanjing Vazyme Biotech Co Stocks history

YEARNUMBER OF STOCKS (undefined CNY)
2026e394.2
2025e394.2
2024e394.2
2023394.2
2022400.01
2021362.72
2020400.01
2019400.01
2018400.01

Nanjing Vazyme Biotech Co Aktienanalyse

What does Nanjing Vazyme Biotech Co do?

Nanjing Vazyme Biotech Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Nanjing Vazyme Biotech Co's Shares Outstanding

Nanjing Vazyme Biotech Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Nanjing Vazyme Biotech Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Nanjing Vazyme Biotech Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Nanjing Vazyme Biotech Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Nanjing Vazyme Biotech Co Stock

How many stocks are there of Nanjing Vazyme Biotech Co?

The current number of stocks of Nanjing Vazyme Biotech Co is 394.2 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Nanjing Vazyme Biotech Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Nanjing Vazyme Biotech Co evolved in recent years?

The number of shares of Nanjing Vazyme Biotech Co has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Nanjing Vazyme Biotech Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Nanjing Vazyme Biotech Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Nanjing Vazyme Biotech Co pay?

Over the past 12 months, Nanjing Vazyme Biotech Co paid a dividend of 1.25 CNY . This corresponds to a dividend yield of about 5.32 %. For the coming 12 months, Nanjing Vazyme Biotech Co is expected to pay a dividend of 1.38 CNY.

What is the dividend yield of Nanjing Vazyme Biotech Co?

The current dividend yield of Nanjing Vazyme Biotech Co is 5.32 %.

When does Nanjing Vazyme Biotech Co pay dividends?

Nanjing Vazyme Biotech Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nanjing Vazyme Biotech Co?

Nanjing Vazyme Biotech Co paid dividends every year for the past 5 years.

What is the dividend of Nanjing Vazyme Biotech Co?

For the upcoming 12 months, dividends amounting to 1.38 CNY are expected. This corresponds to a dividend yield of 5.87 %.

In which sector is Nanjing Vazyme Biotech Co located?

Nanjing Vazyme Biotech Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nanjing Vazyme Biotech Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nanjing Vazyme Biotech Co from 6/7/2023 amounting to 1.25 CNY, you needed to have the stock in your portfolio before the ex-date on 6/7/2023.

When did Nanjing Vazyme Biotech Co pay the last dividend?

The last dividend was paid out on 6/7/2023.

What was the dividend of Nanjing Vazyme Biotech Co in the year 2023?

In the year 2023, Nanjing Vazyme Biotech Co distributed 0.3 CNY as dividends.

In which currency does Nanjing Vazyme Biotech Co pay out the dividend?

The dividends of Nanjing Vazyme Biotech Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nanjing Vazyme Biotech Co

Our stock analysis for Nanjing Vazyme Biotech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nanjing Vazyme Biotech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.